EyeVerify CEO Toby Rush offers an update on hiring plans, global expansion
October 11, 2016 | Bobby Burch
When your goal is to more than quadruple your company’s user base — from 450 million to 2 billion people — it usually entails a world of change.
And such is the case for Kansas City-based EyeVerify, a biometrics startup that recently sold to Alibaba affiliate Ant Financial for more than $100 million. Startland News spoke with EyeVerify CEO Toby Rush about what the sale means for the firm’s local operations and Kansas City as a whole. Check out the video below for more!
Featured Business
2016 Startups to Watch
stats here
Related Posts on Startland News
Cybersecurity automation: How to do more with less
Editor’s note: The opinions expressed in this commentary are the author’s alone. BARR Advisory, which has offices in Kansas City, is a cloud-based security and compliance solutions provider, specializing in cybersecurity, is a financial partner of Startland News. Click here to check out more from this Cybersecurity Month series from BARR Advisory. In today’s rapidly…
ARtechBBQ is back, bringing Oktoberfest vibes to KC’s best-smelling celebration of tech
While the party has grown larger each year, Greg Kratofil said, the goal of the ARtechBBQ remains the same: to highlight Kansas City’s tech community at what he calls the closest thing the city has to Mardi Gras. The hotly-anticipated, one-night-only event returns 6 p.m. to midnight Nov. 1 at the Kansas Speedway during the…
CEO: Selling US Toy allows family owners to refocus on innovative early childhood learning tools
Selling the family-owned US Toy business — a brand that became a household name over its 70-year run — allows its third-generation ownership to shift their full attention to a sister company that serves the early childhood industry with STEM resources, classroom furniture, playground equipment, and more, said Seth Freiden. Constructive Playthings, led today by…
Biotech startup’s latest partnership gets its UniPen into the hands of more pharmacists
A new strategic partnership for Love Lifesciences is expected to leverage its core product — a safe, self-administered injection medication delivery system — to new groups of like-minded, innovation-first companies, said Nick Love. The Overland Park biotech startup on Wednesday announced the deal with the Alliance for Pharmacy Compounding (APC), a leading trade organization, to…